Revenue for Zimmer Biomet Holdings (ZBH)
According to Zimmer Biomet Holdings's latest reported financial statements, the company's current revenue (TTM) is $8.23B USD. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings (not a live revenue-per-second estimate).
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingRevenueSwitch metric
TTM (last 4 quarters)
$8.23B
YoY change
+7.2%
5Y CAGR
+6.1%
Peak year (2025)
$8.23B
Cumulative revenue
$132.19B
Revenue history chart for Zimmer Biomet Holdings (ZBH) from 1998 to 2025
Revenue history table for Zimmer Biomet Holdings (ZBH) from 1998 to 2025
| Fiscal year | Period ended | Reported | Revenue | YoY |
|---|---|---|---|---|
| 2025 | $8.23B | +7.2% | ||
| 2024 | $7.68B | +3.8% | ||
| 2023 | $7.39B | +6.5% | ||
| 2022 | $6.94B | +1.6% | ||
| 2021 | $6.83B | +11.4% | ||
| 2020 | $6.13B | -23.2% | ||
| 2019 | $7.98B | +0.6% | ||
| 2018 | $7.93B | +1.7% | ||
| 2017 | $7.80B | +1.8% | ||
| 2016 | $7.67B | +27.9% | ||
| 2015 | $6.00B | +28.3% | ||
| 2014 | $4.67B | +1.1% | ||
| 2013 | $4.62B | +3.4% | ||
| 2012 | $4.47B | +0.4% | ||
| 2011 | $4.45B | +5.5% | ||
| 2010 | $4.22B | +3.0% | ||
| 2009 | $4.10B | -0.6% | ||
| 2008 | $4.12B | +5.7% | ||
| 2007 | $3.90B | +11.5% | ||
| 2006 | $3.50B | +6.4% | ||
| 2005 | $3.29B | +10.2% | ||
| 2004 | $2.98B | +56.8% | ||
| 2003 | $1.90B | +38.5% | ||
| 2002 | $1.37B | +16.4% | ||
| 2001 | $1.18B | +13.3% | ||
| 2000 | $1.04B | +10.8% | ||
| 1999 | $939.00M | +9.1% | ||
| 1998 | $861.00M | — |
Revenue values are taken from Zimmer Biomet Holdings's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Zimmer Biomet Holdings (ZBH) revenue is $8.23B – grew 7.2% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Zimmer Biomet Holdings revenue compounded at +6.1% per year, sustaining 5 straight years of year-over-year growth.
Across the available history, revenue reached its high of $8.23B in 2025 and its low of $861.00M in 1998.
Zimmer Biomet Holdings (ZBH) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $65.09B.
Zimmer Biomet Holdings Revenue by Year
Zimmer Biomet Holdings Revenue 2025: $8.23B
Zimmer Biomet Holdings revenue in 2025 was $8.23B, grew 7.2% from 2024. This figure represents the highest annual value in the available history.
Zimmer Biomet Holdings Revenue 2024: $7.68B
Zimmer Biomet Holdings revenue in 2024 was $7.68B, edged up 3.8% from 2023.
Zimmer Biomet Holdings Revenue 2023: $7.39B
Zimmer Biomet Holdings revenue in 2023 was $7.39B, grew 6.5% from 2022.
Zimmer Biomet Holdings Revenue 2022: $6.94B
Zimmer Biomet Holdings revenue in 2022 was $6.94B, edged up 1.6% from 2021.
Zimmer Biomet Holdings Revenue 2021: $6.83B
Zimmer Biomet Holdings revenue in 2021 was $6.83B.
See more financial history for Zimmer Biomet Holdings (ZBH).
Sector peers — Revenue
Companies in the same sector as Zimmer Biomet Holdings, ranked by their latest revenue.
| Company | Revenue | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $447.57B | Healthcare |
| Novo Nordisk A/S (NVO) | $309.06B | Healthcare |
| Johnson & Johnson (JNJ) | $94.19B | Healthcare |
| Eli Lilly and Company (LLY) | $65.18B | Healthcare |
| Merck & Co., Inc. (MRK) | $65.01B | Healthcare |
| AbbVie Inc. (ABBV) | $61.16B | Healthcare |
| AstraZeneca PLC (AZN) | $58.74B | Healthcare |
| Amgen Inc. (AMGN) | $36.74B | Healthcare |
Frequently asked questions
What is Zimmer Biomet Holdings's revenue?
- Latest reported revenue for Zimmer Biomet Holdings (ZBH) is $8.23B (period ending December 31, 2025).
How has Zimmer Biomet Holdings revenue changed year-over-year?
- Zimmer Biomet Holdings (ZBH) revenue changed +7.2% year-over-year on the latest annual filing.
What is the long-term growth rate of Zimmer Biomet Holdings revenue?
- Zimmer Biomet Holdings (ZBH) revenue compound annual growth rate is +6.1% over the most recent 5 years available.
When did Zimmer Biomet Holdings revenue hit its highest annual value?
- Zimmer Biomet Holdings revenue reached its highest annual value of $8.23B in 2025.
What was Zimmer Biomet Holdings revenue in 2024?
- Zimmer Biomet Holdings (ZBH) revenue in 2024 was $7.68B.
What was Zimmer Biomet Holdings revenue in 2025?
- Zimmer Biomet Holdings (ZBH) revenue in 2025 was $8.23B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ZBH Overview
Company profile, financial tools, and key metrics
ZBH Revenue Counter
Earns $261.02 every second. See per minute, hour, and day.
ZBH Earnings Counter
Earns $22.36 per second net profit. See per minute, hour, and day.
ZBH Economic Scale
Exceeds Barbados's GDP. Compare with world economies.
ZBH What If Invested
What if you had invested $1,000? See historical returns from any date.
ZBH How It Makes Money
Discover visual breakdown of $8.23B in revenue — where it comes from and where it goes.
ZBH Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ZBH Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ZBH Daily Price Character
Steady · 50.9% historical win rate (green days). Streaks & record days.
ZBH Buybacks
4.08% TTM buyback yield. Shareholder yield & SBC comparison.
ZBH Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.
ZBH Dividend Profile
Yield: 1.20%. Safety: 6/8. See full history.
ZBH Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ZBH Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.